* Jaguar Health Inc JAGX.OQ reported a quarterly adjusted
loss
of 12 cents per share for the quarter ended in June. The mean
expectation of two analysts for the quarter was for a loss of 22
cents per share.
* Revenue rose 658.7% to $2.92 million from a year ago;
analysts
expected $3.10 million.
* Jaguar Health Inc's reported EPS for the quarter was a
loss
of 12 cents.
* The mean earnings estimate of analysts had fallen by
about 7.3%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Jaguar Health Inc shares had fallen by 9.4% this
quarter and
lost 74.4% so far this year.
* The company reported a quarterly loss of $9.37 million.
* Wall Street's median 12-month price target for Jaguar
Health Inc
is $10.88
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data August 22
at 01:31 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2022 -0.22 -0.12 Beat
Mar. 31 2022 -0.17 -0.40 Missed
Dec. 31 2021 -0.09 -0.31 Missed
Sep. 30 2021 -0.17 -0.27 Missed